Skip to main content
SpringerLink
Log in

Rational use of the EAC real-time quantitative PCR protocol in chronic myelogenous leukemia: report of three false-negative cases at diagnosis

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2

References

  1. Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – a Europe Against Cancer program. Leukemia 2003; 17: 2318–2357.

    Article  CAS  PubMed  Google Scholar 

  2. Pane F, Intrieri M, Quintarelli C, Izzo B, Muccioli GC, Salvatore F . BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations. Oncogene 2002; 21: 8652–8667.

    Article  CAS  PubMed  Google Scholar 

  3. Sugimoto T, Ijima K, Hisatomi H, Murayama T, Mizuno I, Hato A et al. Second case of CML with aberrant BCR-ABL fusion transcript (e8/a2) with insertion of an inverted ABL intron 1b sequence. Am J Hematol 2004; 77: 164–166.

    Article  PubMed  Google Scholar 

  4. Cross NC, Melo JV, Feng L, Goldman JM . An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders. Leukemia 1994; 8: 186–189.

    CAS  PubMed  Google Scholar 

  5. van der Velden VH, Hochhaus A, Cazzaniga G, Szczepanski T, Gabert J, van Dongen JJ . Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia 2003; 17: 1013–1034.

    Article  CAS  PubMed  Google Scholar 

  6. Emig M, Saubele S, Wittor H, Weiber A, Reiter A, Willer A et al. Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR. Leukemia 1999; 13: 1825–1832.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Genetics, University Hospital Erasme, Brussels, Belgium

    B Dessars, H El Housni & P Heimann

  2. Department of Human Genetics, Molecular Hematology Unit, Pathology Institute, CHU Sart-Tilman, Liege, Belgium

    F Lambert

  3. Department of Hematology, University Hospital Erasme, Brussels, Belgium

    A Kentos

  4. Laboratory of Cytogenetics, Jules Bordet Institute, Brussels, Belgium

    P Heimann

Authors
  1. B Dessars
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H El Housni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F Lambert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Kentos
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P Heimann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P Heimann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dessars, B., El Housni, H., Lambert, F. et al. Rational use of the EAC real-time quantitative PCR protocol in chronic myelogenous leukemia: report of three false-negative cases at diagnosis. Leukemia 20, 886–888 (2006). https://doi.org/10.1038/sj.leu.2404174

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404174

  • Springer Nature Limited

This article is cited by

Search

Navigation